This company has been marked as potentially delisted and may not be actively trading. NASDAQ:SWAV Shockwave Medical (SWAV) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Shockwave Medical Stock (NASDAQ:SWAV) 30 days 90 days 365 days Advanced Chart Get Shockwave Medical alerts:Sign Up Key Stats Today's Range$334.75▼$334.7550-Day Range$328.87▼$334.8352-Week Range$157.00▼$334.90VolumeN/AAverage Volume968,088 shsMarket Capitalization$12.57 billionP/E Ratio78.21Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system; and Reducer, a device to treat refractory angina. In addition, the company develops COSIRA-II trial; shockwave C2 Aero, a coronary IVL catheter; shockwave javelin coronary, a non-balloon-based catheter platform to treat of tight, difficult-to-cross coronary lesions; shockwave L6; shockwave E8 catheter, to target long peripheral artery lesions; shockwave javelin peripheral, a non-balloon-based catheter platform, to treat tight, difficult-to-cross peripheral lesions. Further, it offers shockwave carotid IVL, a purpose-built IVL System to treat calcified carotid artery lesions; and Shockwave Crescendo, a platform developed to treat calcified, stenotic heart valves. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California. Read More Receive SWAV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Shockwave Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SWAV Stock News HeadlinesShockwave Medical Launches Novel Forward Intravascular Lithotripsy Platform in U.S. to Transform Treatment of Difficult-to-Cross Calcified LesionsMarch 4, 2025 | finance.yahoo.comJ&J’s Shockwave strengths IVL grasp with new US catheter launchSeptember 17, 2024 | msn.comWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was projected. According to Porter Stansberry, this is panic-level borrowing… and a clear sign we’re nearing America’s financial breaking point. In his latest emergency briefing, Porter outlines why the cracks in our system are widening fast—and how Trump’s policies may be accelerating the collapse. More importantly, he reveals three moves you can make now to protect and potentially grow your wealth before the levee breaks.August 28 at 2:00 AM | Porter & Company (Ad)New noninvasive technique provides effective treatment for urinary stonesSeptember 12, 2024 | msn.comBalancing Growth and Challenges: A Hold Rating for Johnson & Johnson’s Medtech Division Amidst China HeadwindsSeptember 6, 2024 | markets.businessinsider.comBaird Q2 2024 Small/Mid Cap Growth Equity Fund CommentaryAugust 22, 2024 | seekingalpha.comIntroducing OMNIWave(TM): Revolutionizing Treatment with Advanced Shockwave Technology and Comprehensive Business SolutionsAugust 15, 2024 | markets.businessinsider.comGRPM: Why This Mid-Cap GARP ETF Deserves An UpgradeAugust 2, 2024 | seekingalpha.comSee More Headlines SWAV Stock Analysis - Frequently Asked Questions How were Shockwave Medical's earnings last quarter? Shockwave Medical, Inc. (NASDAQ:SWAV) issued its quarterly earnings results on Monday, May, 6th. The company reported $1.44 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.99 by $0.45. The firm's quarterly revenue was up 35.8% compared to the same quarter last year. When did Shockwave Medical IPO? Shockwave Medical (SWAV) raised $75 million in an IPO on Thursday, March 7th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers. What other stocks do shareholders of Shockwave Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Shockwave Medical investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Arista Networks (ANET), ServiceNow (NOW) and CrowdStrike (CRWD). Company Calendar Last Earnings5/06/2024Today8/28/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:SWAV CIK1642545 Webwww.shockwavemedical.com Phone(877) 775-4846FaxN/AEmployees1,468Year FoundedN/AProfitability EPS (Trailing Twelve Months)$4.28 Trailing P/E Ratio78.21 Forward P/E Ratio66.29 P/E Growth2.43Net Income$147.28 million Net Margins20.75% Pretax Margin23.29% Return on Equity24.79% Return on Assets11.95% Debt Debt-to-Equity Ratio0.97 Current Ratio13.81 Quick Ratio12.61 Sales & Book Value Annual Sales$787.97 million Price / Sales15.95 Cash Flow$4.31 per share Price / Cash Flow77.61 Book Value$20.02 per share Price / Book16.72Miscellaneous Outstanding Shares37,544,000Free Float36,268,000Market Cap$12.57 billion OptionableOptionable Beta0.88 The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (NASDAQ:SWAV) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shockwave Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shockwave Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access